Gain Therapeutics Inc. (GANX)

GANX trades at $1.92, 4.0% below the near-term max pain of $2 expiring Oct 17, 2025 (13 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($1-$2), reflecting growing call interest at higher strikes. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for GANX shows an upward trend from 1 to 2, suggesting bullish positioning in longer-dated options. The 80% spread signals divergent expectations across timeframes. Most levels below 1.92 may cap rallies. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.